Lifecore Biomedical

LFCR57

$5.62arrow_drop_up8.07%$0.42

LFCR57

$5.62

arrow_drop_up8.07%$0.42

Performance History

Key Stats
Open	$5.35
Prev. Close	$5.20
EPS	0.25
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$157.27M

	LOW	HIGH
Day Range	5.28	5.77
52 Week Range	3.68	8.90

Ratios







EPS	0.25

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Lifecore Biomedical (LFCR)

Lifecore Biomedical, Inc. (LFCR) is a leading biotechnology company specializing in the development and commercialization of innovative medical devices and products. With a strong focus on research and development, Lifecore is at the forefront of cutting-edge advancements in the healthcare industry. The company's mission is to improve patient outcomes and enhance quality of life through the delivery of superior medical solutions.

Lifecore Biomedical, Inc. is known for its extensive portfolio of medical devices and products, which includes advanced drug delivery systems, biomaterials, and regenerative medicine solutions. The company's products are designed to address a wide range of medical conditions, from chronic diseases to acute injuries. Lifecore's commitment to innovation and excellence has made it a trusted partner and supplier for healthcare providers worldwide.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO: Mr. James G. Hall
Headquarters: Chaska
Employees: 689
Exchange: NASDAQ

Keep an eye on Lifecore Biomedical

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Lifecore Biomedical's (LFCR) price per share?

The current price per share for Lifecore Biomedical (LFCR) is $5.62. The stock has seen a price change of $0.42 recently, indicating a 8.08% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Lifecore Biomedical (LFCR)?

For Lifecore Biomedical (LFCR), the 52-week high is $8.9, which is 58.36% from the current price. The 52-week low is $3.68, the current price is 52.72% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Lifecore Biomedical (LFCR) a growth stock?

Lifecore Biomedical (LFCR) has shown an average price growth of 0.41% over the past three years. It has received a score of 42 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Lifecore Biomedical as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Lifecore Biomedical (LFCR) stock price performance year to date (YTD)?

As of the latest data, Lifecore Biomedical (LFCR) has a year-to-date price change of -11.91%. Over the past month, the stock has experienced a price change of 0.36%. Over the last three months, the change has been 14.93%. Over the past six months, the figure is -21.73%.

help

Is Lifecore Biomedical (LFCR) a profitable company?

Lifecore Biomedical (LFCR) has a net income of $9.33M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 32.63% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 7.62% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $128.26M, although specific revenue growth data is currently not available. The gross profit is $41.85M. Operating income is noted at -$7.19M. Furthermore, the EBITDA is $1.17M.

help

What is the market capitalization of Lifecore Biomedical (LFCR)?

Lifecore Biomedical (LFCR) has a market capitalization of $157.27M. The average daily trading volume is 207.02K, indicating the stock's liquidity and investor engagement.

News

Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lifecore Biomedical, Inc. (LFCR)

LIFECORE BIOMEDICAL

SECURITIES CLASS ACTION

FINANCIAL REPORTING

PUBLIC STATEMENTS

9/17/2024

LFCR DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important September 27 Deadline in Securities Class Action – LFCR

LFCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lifecore Biomedical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

DEADLINE ALERT for CAE, AAL, ODD, LFCR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

CAE INC.

AMERICAN AIRLINES GROUP INC.

ODDITY TECH LTD.

LIFECORE BIOMEDICAL, INC.

CLASS ACTION LAWSUIT

SHAREHOLDER

9/16/2024

DEADLINE ALERT for CAE, AAL, ODD, LFCR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

LIFECORE BIOMEDICAL

SECURITIES CLASS ACTION

FINANCIAL REPORTING

INTERNAL CONTROLS

9/13/2024

LFCR DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LFCR

Performance History

Score Breakdown

Welcome to Stocklytics

Analyst Forecast

Analyst Ratings

About Lifecore Biomedical (LFCR)

Keep an eye on Lifecore Biomedical

Frequently Asked Questions

What is Lifecore Biomedical's (LFCR) price per share?

What is the 52-week high and low for Lifecore Biomedical (LFCR)?

Is Lifecore Biomedical (LFCR) a growth stock?

What is Lifecore Biomedical (LFCR) stock price performance year to date (YTD)?

Is Lifecore Biomedical (LFCR) a profitable company?

What is the market capitalization of Lifecore Biomedical (LFCR)?

News

Sign up for our newsletter

Take Your Investments to a Whole New Level